1. Home
  2. SRPT vs SID Comparison

SRPT vs SID Comparison

Compare SRPT & SID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • SID
  • Stock Information
  • Founded
  • SRPT 1980
  • SID 1941
  • Country
  • SRPT United States
  • SID Brazil
  • Employees
  • SRPT N/A
  • SID N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • SID Steel/Iron Ore
  • Sector
  • SRPT Health Care
  • SID Industrials
  • Exchange
  • SRPT Nasdaq
  • SID Nasdaq
  • Market Cap
  • SRPT 2.0B
  • SID 1.9B
  • IPO Year
  • SRPT 1997
  • SID 1997
  • Fundamental
  • Price
  • SRPT $18.46
  • SID $1.43
  • Analyst Decision
  • SRPT Hold
  • SID Strong Sell
  • Analyst Count
  • SRPT 30
  • SID 1
  • Target Price
  • SRPT $44.37
  • SID $1.30
  • AVG Volume (30 Days)
  • SRPT 9.6M
  • SID 2.8M
  • Earning Date
  • SRPT 08-06-2025
  • SID 07-31-2025
  • Dividend Yield
  • SRPT N/A
  • SID 5.71%
  • EPS Growth
  • SRPT N/A
  • SID N/A
  • EPS
  • SRPT N/A
  • SID N/A
  • Revenue
  • SRPT $2,481,531,000.00
  • SID $8,202,474,486.00
  • Revenue This Year
  • SRPT $9.41
  • SID $5.24
  • Revenue Next Year
  • SRPT N/A
  • SID $0.91
  • P/E Ratio
  • SRPT N/A
  • SID N/A
  • Revenue Growth
  • SRPT 64.89
  • SID 2.22
  • 52 Week Low
  • SRPT $10.42
  • SID $1.24
  • 52 Week High
  • SRPT $138.81
  • SID $2.50
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 48.03
  • SID 54.57
  • Support Level
  • SRPT $17.95
  • SID $1.26
  • Resistance Level
  • SRPT $19.61
  • SID $1.39
  • Average True Range (ATR)
  • SRPT 1.20
  • SID 0.05
  • MACD
  • SRPT -0.06
  • SID 0.02
  • Stochastic Oscillator
  • SRPT 19.69
  • SID 80.43

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.

Share on Social Networks: